Review article: how the intestinal microbiota may reflect disease activity and influence therapeutic outcome in inflammatory bowel disease.
Clara CaenepeelNasim Sadat Seyed TabibSara Vieira-SilvaSéverine VermeirePublished in: Alimentary pharmacology & therapeutics (2020)
The intestinal microbiota in IBD carries a set of promising biomarkers of disease activity and prediction of therapeutic outcome. Current insights may also help in designing microbiota modulation strategies to improve outcomes in IBD.